Overview

Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the allergenicity of Amphadase® in healthy volunteers using an intradermal skin test.
Phase:
Phase 2
Details
Lead Sponsor:
Amphastar Pharmaceuticals, Inc.
Treatments:
Histamine